Zivo Bioscience, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Zivo Bioscience, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q3 2024.
  • Zivo Bioscience, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 8, 2024 was 3.55M shares, a 94.9% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 3.55M +1.73M +94.9% Nov 8, 2024 10-Q 2024-11-14
Q2 2024 3.37M -7.08M -67.8% Aug 9, 2024 10-Q 2024-08-14
Q1 2024 2.78M -6.64M -70.5% Mar 12, 2024 10-K 2024-03-15
Q3 2023 1.82M -7.6M -80.7% Nov 9, 2023 10-Q 2023-11-13
Q2 2023 10.4M +1.03M +10.9% Aug 1, 2023 10-Q 2023-08-14
Q1 2023 9.42M 0 0% Feb 22, 2023 10-K 2023-03-14
Q3 2022 9.42M 0 0% Nov 10, 2022 10-Q 2022-11-14
Q2 2022 9.42M +201K +2.18% Aug 1, 2022 10-Q 2022-08-04
Q1 2022 9.42M -409M -97.7% Apr 19, 2022 10-K/A 2022-05-02
Q3 2021 9.42M -400M -97.7% Nov 11, 2021 10-Q/A 2022-04-21
Q2 2021 9.22M -397M -97.7% Aug 13, 2021 10-Q 2021-08-16
Q1 2021 418M +16.1M +4.02% Feb 25, 2021 10-K 2021-02-25
Q3 2020 410M +50.8M +14.2% Nov 5, 2020 10-Q 2020-11-12
Q2 2020 407M +59.4M +17.1% Aug 12, 2020 10-Q 2020-08-13
Q1 2020 402M +210M +109% Mar 26, 2020 10-K 2020-03-26
Q3 2019 359M +190M +112% Oct 25, 2019 10-Q 2019-10-28
Q2 2019 347M +182M +111% Aug 7, 2019 10-Q 2019-08-07
Q1 2019 192M +50.5M +35.6% May 13, 2019 10-Q 2019-05-13
Q4 2018 180M +38.8M +27.5% Feb 11, 2019 10-K 2019-02-12
Q3 2018 169M +28.1M +19.9% Nov 14, 2018 10-Q 2018-11-14
Q2 2018 165M +24.6M +17.5% Aug 13, 2018 10-Q 2018-08-14
Q1 2018 142M +4.68M +3.42% Apr 18, 2018 10-Q 2018-04-23
Q4 2017 141M Feb 13, 2018 10-K 2018-02-21
Q3 2017 141M +4.16M +3.04% Oct 19, 2017 10-Q 2017-10-19
Q2 2017 140M +7.39M +5.56% Aug 11, 2017 10-Q 2017-08-11
Q1 2017 137M +4.32M +3.26% Mar 29, 2017 10-K 2017-03-31
Q3 2016 137M +4.7M +3.56% Nov 13, 2016 10-Q 2016-11-14
Q2 2016 133M +2M +1.53% Aug 12, 2016 10-Q 2016-08-12
Q1 2016 133M +2.93M +2.26% Mar 29, 2016 10-K 2016-03-29
Q3 2015 132M +3.49M +2.71% Nov 13, 2015 10-Q 2015-11-13
Q2 2015 131M +3.6M +2.83% Aug 12, 2015 10-Q 2015-08-13
Q1 2015 130M +7.38M +6.03% Mar 30, 2015 10-K 2015-04-06
Q3 2014 129M +14M +12.2% Nov 13, 2014 10-Q 2014-11-14
Q2 2014 127M +18M +16.5% Aug 14, 2014 10-Q 2014-08-14
Q1 2014 122M +16.7M +15.8% Mar 19, 2014 10-K 2014-03-31
Q3 2013 115M +11.2M +10.9% Nov 6, 2013 10-Q 2013-11-12
Q2 2013 109M +7.45M +7.32% Aug 6, 2013 10-Q 2013-08-13
Q1 2013 106M +5.63M +5.63% Apr 25, 2013 10-Q 2013-05-06
Q3 2012 103M +5.6M +5.73% Nov 6, 2012 10-Q/A 2012-11-19
Q2 2012 102M Aug 8, 2012 10-Q/A 2012-08-31
Q1 2012 100M Mar 20, 2012 10-K 2012-03-30
Q4 2011 98.6M Nov 17, 2011 10-Q 2011-11-21
Q3 2011 97.8M Aug 17, 2011 10-Q/A 2011-09-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.